Publication:
Acquired von Willebrand Syndrome in a Patient with Ewing Sarcoma

dc.authorscopusid12139290200
dc.authorscopusid8876487000
dc.authorscopusid6602111071
dc.authorscopusid6602451205
dc.authorscopusid6602890385
dc.authorscopusid7003692769
dc.authorscopusid12139111700
dc.contributor.authorElli, M.
dc.contributor.authorPinarli, F.G.
dc.contributor.authorDaǧdemir, A.
dc.contributor.authorDabak, N.
dc.contributor.authorFišgin, T.
dc.contributor.authorSelçuk, M.B.
dc.contributor.authorSultansuyu, S.
dc.date.accessioned2020-06-21T15:29:08Z
dc.date.available2020-06-21T15:29:08Z
dc.date.issued2006
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Elli] Murat, Department of Paediatric Oncology, Ondokuz Mayis Üniversitesi, Samsun, Turkey, Department of Paediatric Oncology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Pinarli] Faruk Guclu, Department of Paediatric Oncology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Daǧdemir] Ayhan, Department of Paediatric Oncology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Dabak] Nevzat, Dept. Orthopaedics and Traumatology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Fišgin] Tunç, Department of Paediatric Haematology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Selçuk] Mustafa Bekir, Department of Radiology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Sultansuyu] Sevinç, Department of Paediatric Haematology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Acar] Sabri, Department of Paediatric Oncology, Ondokuz Mayis Üniversitesi, Samsun, Turkeyen_US
dc.description.abstractAcquired von Willebrand syndrome is a rare bleeding disorder with clinical and laboratory features closely resembling to hereditary von Willebrand disease. The syndrome may accompany various conditions, including malignant disorders, most often with Wilms tumor and adrenal cell carcinoma. In this report, the authors present a patient with AvWS in association with Ewing sarcoma for the first time in the literature. The abnormal bleeding tendency was successfully treated with fresh frozen plasma and did not recur after the first two courses of chemotherapy with clinical improvement. Copyright © Taylor & Francis Group, LLC.en_US
dc.identifier.doi10.1080/08880010500457749
dc.identifier.endpage114en_US
dc.identifier.issn0888-0018
dc.identifier.issn1521-0669
dc.identifier.issue2en_US
dc.identifier.pmid16651239
dc.identifier.scopus2-s2.0-31644434537
dc.identifier.scopusqualityQ3
dc.identifier.startpage111en_US
dc.identifier.urihttps://doi.org/10.1080/08880010500457749
dc.identifier.volume23en_US
dc.identifier.wosWOS:000236144100004
dc.identifier.wosqualityQ3
dc.language.isoenen_US
dc.publisherTaylor & Francis Incen_US
dc.relation.ispartofPediatric Hematology and Oncologyen_US
dc.relation.journalPediatric Hematology and Oncologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAcquired von Willebrand Syndromeen_US
dc.subjectEwing Sarcomaen_US
dc.titleAcquired von Willebrand Syndrome in a Patient with Ewing Sarcomaen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files